1. Home
  2. COCH vs ZTEK Comparison

COCH vs ZTEK Comparison

Compare COCH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.67

Market Cap

51.0M

Sector

Finance

ML Signal

HOLD

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

HOLD

Current Price

$0.57

Market Cap

59.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCH
ZTEK
Founded
1995
2008
Country
United States
Canada
Employees
47
N/A
Industry
Blank Checks
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
59.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
COCH
ZTEK
Price
$0.67
$0.57
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
327.4K
138.8K
Earning Date
05-08-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.37
52 Week High
$1.89
$1.24

Technical Indicators

Market Signals
Indicator
COCH
ZTEK
Relative Strength Index (RSI) 42.69 58.08
Support Level $0.64 $0.55
Resistance Level $0.74 $0.56
Average True Range (ATR) 0.06 0.05
MACD -0.01 0.01
Stochastic Oscillator 10.90 67.02

Price Performance

Historical Comparison
COCH
ZTEK

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

About ZTEK Zentek Ltd.

Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.

Share on Social Networks: